Skip to main content
SpringerLink
Log in

Disorders of Growth and Development

  • Chapter
Challenging Cases in Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

  • 183 Accesses

Abstract

This 4-yr-4-mo-old boy presented to the local pediatric endocrinologist for evaluation of accelerated growth velocity and development of pubic hair over the past year.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sklar CA, Kaplan SL, Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 1980; 51: 548–556.

    Article  PubMed  CAS  Google Scholar 

  2. Gell JS, Atkins B, Margraf L. Adrenarche is associated with decreased 3-beta-hydroxysteroid dehydrogenase expression in the adrenal reticularis. Endocr Res 1996; 22: 723–728.

    PubMed  CAS  Google Scholar 

  3. Klein KO. Editorial: precocious puberty: who has it? Who should be treated? J Clin Endocrinol Metab 1999; 84: 412–414.

    Google Scholar 

  4. Kaplan SL, Grumbach MM. Pathogenesis of sexual precocity. In: Grumbach MM, Sizonenko PC, Aubert ML, eds. Control of the Onset of Puberty. Williams and Wilkins, Baltimore, MD, 1990, pp. 620660.

    Google Scholar 

  5. Lin D, Sugawara T, Strauss JF III, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267: 1828 1831.

    Google Scholar 

  6. Bose HS, Sugawara T, Strauss JF III, Miller WL. The pathophysiology and genetics of congenital lipod adrenal hyperplasia. N Engl J Med 1996; 335: 1870–1878.

    Article  PubMed  CAS  Google Scholar 

  7. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245–291.

    Article  PubMed  CAS  Google Scholar 

  8. New MI. Diagnosis and management of congenital adrenal hyperplasia. Annu Rev Med 1998; 49: 311–328.

    Article  PubMed  CAS  Google Scholar 

  9. Speiser PW, White PC. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Clin Endocrinol 1998; 49: 411–417

    Article  CAS  Google Scholar 

  10. Pang S. Congenital adrenal hyperplasia. Endocrinol Metab Clin N Am 1997; 26: 853–890.

    Article  CAS  Google Scholar 

  11. New MI, Lorenzen F, Lerner A, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57: 320–325.

    Article  PubMed  CAS  Google Scholar 

  12. Therrell B, Berenbaum S, Manter-Kapanke V, et al. Result of screening 1.9 million Texas newborns for 21-hydroxylase deficient congenital adrenal hyperplasia. Pediatrics 1998; 101: 583–590.

    Article  PubMed  Google Scholar 

  13. Wedell A, Thilen A, Ritzen E, et al. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestations. J Clin Endocrinol Metab 1994; 78: 1145–1152.

    Article  PubMed  CAS  Google Scholar 

  14. Krone N, Braun A, Roscher AA, et al. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000; 85: 1059–1065.

    Article  PubMed  CAS  Google Scholar 

  15. Amor M, Parker KL, Globerman H, New MI, White PC. Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1998; 85: 1600–1604.

    Article  Google Scholar 

  16. Speiser P, New M, White P. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14, DR1. N Engl J Med 1988; 90: 584–595.

    Google Scholar 

  17. Tusie-Luna M, Speiser P, Dumic M, et al. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 1991; 5: 685–692.

    Article  PubMed  CAS  Google Scholar 

  18. Thilen A, Nordenstrom A, Hagenfeldt L, et al. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1988; 81: 866–874.

    Google Scholar 

  19. Nordenstrom A, Thilen A, Hagenfeldt L, et al. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 1505–1509.

    Article  PubMed  CAS  Google Scholar 

  20. Root AW. Editorial: neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia-the role of CYP21 analysis. J Clin Endocrinol Metab 1999; 84: 1503–1504.

    Article  PubMed  CAS  Google Scholar 

  21. Girgis R, Winter J. The effect of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1997; 82: 3926–3929.

    Article  PubMed  CAS  Google Scholar 

  22. Silva I, Kater C, Cunha C, et al. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch Dis Child 1997; 77: 214–218.

    Article  PubMed  CAS  Google Scholar 

  23. Blizzard, R. Adult consequences of pediatric endocrine disease, I: congenital adrenal hyperplasia. Growth Gen Hormones 1999; 15: 33–41.

    Google Scholar 

  24. Merke DP, Keil MF, Jones JV, et al. Flutamide, testolactone and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2000; 85: 1114–1120.

    Article  PubMed  CAS  Google Scholar 

  25. Irony I, Cutler G. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitaryadrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 1999; 51: 285–291.

    Article  CAS  Google Scholar 

  26. Wit JM, Van Unen H. Growth of infants with neonatal growth hormone deficiency. Arch Dis Child 1992; 67: 920–924.

    Article  PubMed  CAS  Google Scholar 

  27. Gluckman PD, Gunn Ai, Wray A, et al. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. J Pediatr 1992; 121: 920–923.

    Article  PubMed  CAS  Google Scholar 

  28. DeLuca F, Bernasconi S, Blandino A, et al. Auxological, clinical and neuroradiological findings in infants with early onset growth hormone deficiency. Acta Paediatr Scand 1995; 84: 561–565.

    Article  CAS  Google Scholar 

  29. Reiter E, Martha P. Pharmacological testing of growth hormone secretion. Horm Res 1990; 33: 121–127.

    Article  PubMed  CAS  Google Scholar 

  30. Price DA. GH testing in KIGS: the clinical reality. In: Ranke MB, Wilton P, eds. Growth Hormone Therapy in KIGS-10 Years’ Experience. Huthig GmbH, Heidelberg-Leipzig, Germany, 1999, pp. 73–80.

    Google Scholar 

  31. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995; 80: 1232–1540.

    Article  Google Scholar 

  32. Raiti S, Davis WT, Blizzard RM. A comparison of the effects of insulin hypoglycemia and arginine infusion on release of human growth hormone. Lancet 1967; 2: 1182–1183.

    Article  PubMed  CAS  Google Scholar 

  33. Allen D. Childhood growth hormone (GH) deficiency: statural and psychological effects of long-term GH replacement. The Endocrinologist 1998; 8: 3S - 7S.

    Article  Google Scholar 

  34. Van den Broeck J, Hering P, Van de Lely A, et al. Interpretative difficulties with growth hormone provocative retesting in childhood-onset growth hormone deficiency. Horm Res 1999; 51: 1–9.

    PubMed  Google Scholar 

  35. Kleinberg D, Melmed S. The adult growth hormone deficiency syndrome: signs, symptoms and diagnosis. The Endocrinologist 1998; 8: 85–14S.

    Article  Google Scholar 

  36. Ter Maaten J, de Boer H, Kamp O, et al. Long-term effect of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 1999; 84: 2373–2380.

    Article  PubMed  Google Scholar 

  37. Maghnie M, Strigazzi C, Tinelli C, et al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999; 84: 1324–1328.

    Article  PubMed  CAS  Google Scholar 

  38. Vance M, Mauras N. Growth hormone therapy in adults and children. N Engl J Med 1999; 341: 1206–1216.

    Article  PubMed  CAS  Google Scholar 

  39. Beshyah S, Henderson A, Niththyananthan R, et al. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 1995; 80: 356–363.

    Article  PubMed  CAS  Google Scholar 

  40. Baum H, Biller B, Finkelstein J, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency: a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 883–890.

    PubMed  CAS  Google Scholar 

  41. Pollack IF. Brain tumors in children. N Engl J Med 1994; 331: 1501–1507.

    Article  Google Scholar 

  42. Robertson PL. Pediatric brain tumors. Endocrinol Metab Clin N Am 1999; 28: 323–339.

    Google Scholar 

  43. Albright AL. Pediatric brain tumors. Cancer J Clin 1993; 43: 272–288.

    Article  CAS  Google Scholar 

  44. Pollack IF. Pediatric brain tumors. Semin Surg Oncol 1999; 16: 73–90.

    Article  PubMed  CAS  Google Scholar 

  45. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 1999; 28: 81–117.

    Article  CAS  Google Scholar 

  46. Kuttesch JF. The Paulino/Wen/Mohideen article reviewed. Oncology 1999; 13: 529–530.

    Google Scholar 

  47. Jacobson DM. Gliomas of the anterior visual pathways. Neurosurg Clin N Am 1999; 10: 683–698.

    PubMed  CAS  Google Scholar 

  48. Paulino AC, Wen BC, Mohideen MN. Controversies in the management of intracranial germinomas. Oncology 1999; 3: 513–521.

    Google Scholar 

  49. Huh SJ, Shin KH, Kim IH, et al. Radiotherapy of intracranial germinomas. Radiother Oncol 1996; 38: 19–23.

    Article  PubMed  CAS  Google Scholar 

  50. Aoyama H, Shirato H, Kakuto Y, et al. Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol 1998; 47: 201–205.

    Article  PubMed  CAS  Google Scholar 

  51. Dearnaley DP, A’Hern RP, Whittaker S, et al. Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962–1987. Int J Radiat Oncol Biol Phys 1990; 18: 773–781.

    Article  PubMed  CAS  Google Scholar 

  52. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than 3 yr of age with malignant brain tumors. N Engl J Med 1993; 328: 1725–1731.

    Article  PubMed  CAS  Google Scholar 

  53. Ellenberg L, McComb JG, Siegel, SE, et al. Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurg 1987; 21: 638–644.

    Article  CAS  Google Scholar 

  54. Radcliffe J, Packer RJ, Atkins TE, et al. Three-and four-year cognitive outcome in children with non-cortical brain tumors treated with whole-brain radiotherapy. Ann Neurol 1992; 32: 551–554.

    Article  PubMed  CAS  Google Scholar 

  55. Duffner PK, Cohen ME, Voorhess ML, et al. Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer 1985; 56: 2189–2193.

    Article  PubMed  CAS  Google Scholar 

  56. Matsutani M, Sano K, Takakura K, et al. Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors. Child’s Nery Syst 1998; 14: 59–62.

    Article  CAS  Google Scholar 

  57. Sawamura Y, Shirato H, Ikeda J, et al. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed CNS germinoma. J Neurosurg 1998; 66–72.

    Google Scholar 

  58. Baranzelli MC, Patte C, Bouffet E, et al. Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer 1997; 80: 1792–1797.

    Article  PubMed  CAS  Google Scholar 

  59. Calaminus G, Bamberg M, Baranzelli MC, et al. Intracranial germ cell tumors: a comprehensive update of the european data. Neuropediatrics 1994; 25: 26–32.

    Article  PubMed  CAS  Google Scholar 

  60. Livesey EA, Hindmarsh PC, Brook CG, et al. Endocrine disorders following treatment of childhood brain tumors. Br J Cancer 1990; 61: 622–625.

    Article  PubMed  CAS  Google Scholar 

  61. Donahue B. Short-and long-term complications of radiation therapy pediatric brain tumors. Pediatr Neurosurg 1992; 18: 207–217.

    Article  PubMed  CAS  Google Scholar 

  62. Clarson CL, Del Maestro RF. Growth failure after treatment of pediatric brain tumors. Pediatrics 1999; 103 (3): E37.

    Article  PubMed  CAS  Google Scholar 

  63. Ross JL, McCauley E, Roeltgen D, et al. Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. J Clin Endocrinol Metab 1996; 81: 926–931.

    Article  PubMed  CAS  Google Scholar 

  64. Newman LS, Rose CS, Maier LA. Medical progress: sarcoidosis. N Engl J Med 1997; 336: 1224–1234.

    Article  PubMed  CAS  Google Scholar 

  65. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin N Am 1996; 25: 699717.

    Google Scholar 

  66. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98: 196–208.

    Article  PubMed  CAS  Google Scholar 

  67. Locascio V, Bonucci E, Imbimbo B. Bone loss in response to long-term glucocorticoid therapy. Bone Miner 1990; 8: 39–51.

    Article  PubMed  CAS  Google Scholar 

  68. Guistina A, Wehrenberg WB. The role of glucocorticoids in the regulation of growth hormone secretion-mechanisms and clinical significance. Trends Endocrinol Metab 1992; 3: 306–311.

    Article  Google Scholar 

  69. Unterman T, Phillips LS. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 1985; 61: 618–626.

    Article  PubMed  CAS  Google Scholar 

  70. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurol 1993; 43: 8–12.

    Article  CAS  Google Scholar 

  71. Sharma OP, Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Arch Int Med 1991; 151: 1317–1321.

    Article  CAS  Google Scholar 

  72. Milman N, Hoffman AL, Big K-E. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis. Acta Pediatr 1998; 87: 871–878.

    Article  CAS  Google Scholar 

  73. Sherman JL, Stern BJ, Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR 1990; 155: 1293–1301.

    Article  PubMed  CAS  Google Scholar 

  74. Miller DH, Kendall BE, Barter S, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988; 38: 378–383.

    Article  PubMed  CAS  Google Scholar 

  75. Campbell IW, Short AI, Douglas AC. Hypothalamic manifestations of sarcoidosis with particular reference to hypothalamic hypothyroidism. In: Jones Williams W, Davies BH, eds. Sarcoidosis. Alpha and Omega, Cardiff, Wales, 1980, p. 579.

    Google Scholar 

  76. Marcille R, McCarthy M, Barton JW, et al. Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 1992; 102: 1444–1449.

    Article  PubMed  CAS  Google Scholar 

  77. DeRemee RA. Sarcoidosis. Mayo Clin Proc 1995; 70: 177–181.

    Article  PubMed  CAS  Google Scholar 

  78. Hafner R, Vogel P. Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 1993; 11: 685–691.

    PubMed  CAS  Google Scholar 

  79. Chadelat KC, Baculard MD, Grimfeld A, et al. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol 1993; 16: 41–47.

    Article  PubMed  CAS  Google Scholar 

  80. Leibowitz SF. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trend Neurosci 1992; 15: 491–497.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Erick J. Richmond MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan D. Rogol MD,PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Medical School, Chicago, IL, USA

    Mark E. Molitch MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Richmond, E.J., Rogol, A.D. (2002). Disorders of Growth and Development. In: Molitch, M.E. (eds) Challenging Cases in Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-277-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-277-7_21

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-249-0

  • Online ISBN: 978-1-59259-277-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation